Onkure Therapeutics Inc Annual Shareholders Meeting Transcript
Good day and welcome to the OnKure Therapeutics, Inc., Annual Meeting of Stockholders. I would now like to turn the conference over to Nick Saccomano. Please go ahead.
Good morning. The meeting is called to order. As indicated, I am Nick Saccomano, President, CEO and the Director of OnKure Therapeutics, and I will act as Chair of the meeting. Rogan Nunn, our Corporate Secretary and General Counsel, will act as Secretary of the meeting and take minutes of the meeting. At this time, I would like to introduce the other directors in attendance.
I would also like to introduce the other corporate officers who are in attendance: Jason Leverone, our Chief Financial Officer; Sam Agresta, our Chief Medical Officer; and Dylan Hartley, our Chief Scientific Officer. Also with us today are Erica Secor and Mike Petri, representing KPMG LLC; and Paul R. Ramirez, representing Broadbridge Financial Solutions. And now I will ask Mr. Nunn to make his report.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
